Design and development of novel series of indole‐3‐sulfonamide ureido derivatives as selective carbonic anhydrase II inhibitors

Indole is a privileged moiety with a wide range of bioactivities, making it a popular scaffold in drug design and development studies as well as in synthetic chemistry. Here, novel urea derivatives of indole, containing sulfonamide at position‐3 of indole, were synthesized using a well‐known tail approach, as carbonic anhydrases (CAs; EC 4.2.1.1) inhibitors. All the newly synthesized molecules were screened for their CA‐inhibitory activity against four clinically relevant isoforms of human‐origin carbonic anhydrase (hCA), that is, hCA I, hCA II, hCA IX, and hCA XII. These compounds were specifically active against hCA II, more than against hCA I, hCA IX, and hCA XII. Derivative 6l was found to be most active, with a Ki value of 7.7 µM against hCA II.

[1]  C. Supuran,et al.  Discovery of a novel series of indolylchalcone-benzenesulfonamide hybrids acting as selective carbonic anhydrase II inhibitors. , 2021, Bioorganic chemistry.

[2]  C. Supuran,et al.  Coumarin‐Thiourea Hybrids Show Potent Carbonic Anhydrase IX and XIII Inhibitory Action , 2020, ChemMedChem.

[3]  Shubham Kumar,et al.  Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors. , 2020, European journal of medicinal chemistry.

[4]  C. Supuran,et al.  Synthesis and carbonic anhydrase inhibition studies of sulfonamide based indole-1,2,3-triazole chalcone hybrids. , 2020, Bioorganic chemistry.

[5]  C. Supuran,et al.  Indole-Based Hydrazones Containing A Sulfonamide Moiety as Selective Inhibitors of Tumor-Associated Human Carbonic Anhydrase Isoforms IX and XII , 2019, International journal of molecular sciences.

[6]  G. Bifulco,et al.  Identification of an indol-based multi-target kinase inhibitor through phenotype screening and target fishing using inverse virtual screening approach. , 2019, European journal of medicinal chemistry.

[7]  C. Supuran,et al.  Enhancement of the tail hydrophobic interactions within the carbonic anhydrase IX active site via structural extension: Design and synthesis of novel N-substituted isatins-SLC-0111 hybrids as carbonic anhydrase inhibitors and antitumor agents. , 2019, European journal of medicinal chemistry.

[8]  C. Supuran,et al.  Synthesis of a new series of 3-functionalised-1-phenyl-1,2,3-triazole sulfamoylbenzamides as carbonic anhydrase I, II, IV and IX inhibitors , 2019, Journal of enzyme inhibition and medicinal chemistry.

[9]  C. Supuran.  Carbon- versus sulphur-based zinc binding groups for carbonic anhydrase inhibitors? , 2018, Journal of enzyme inhibition and medicinal chemistry.

[10]  C. Supuran,et al.  Inhibition studies on a panel of human carbonic anhydrases with N1-substituted secondary sulfonamides incorporating thiazolinone or imidazolone-indole tails , 2018, Journal of enzyme inhibition and medicinal chemistry.

[11]  F. Sonmez,et al.  Synthesis and biological evaluation of novel coumarin-chalcone derivatives containing urea moiety as potential anticancer agents , 2017 .

[12]  C. Supuran,et al.  Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors. , 2017, ACS medicinal chemistry letters.

[13]  C. Supuran,et al.  Structure activity study of carbonic anhydrase IX: Selective inhibition with ureido-substituted benzenesulfonamides. , 2017, European journal of medicinal chemistry.

[14]  R. McKenna,et al.  Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011–2016) , 2016, Expert opinion on therapeutic patents.

[15]  C. Supuran,et al.  4-Arylbenzenesulfonamides as Human Carbonic Anhydrase Inhibitors (hCAIs): Synthesis by Pd Nanocatalyst-Mediated Suzuki-Miyaura Reaction, Enzyme Inhibition, and X-ray Crystallographic Studies. , 2016, Journal of medicinal chemistry.

[16]  Abdul-Malek S. Al-Tamimi,et al.  Inhibition studies of quinazoline-sulfonamide derivatives against the γ-CA (PgiCA) from the pathogenic bacterium, Porphyromonas gingivalis , 2015, Journal of enzyme inhibition and medicinal chemistry.

[17]  C. Supuran,et al.  New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII , 2015, Journal of enzyme inhibition and medicinal chemistry.

[18]  C. Supuran,et al.  Drosophila melanogaster: a model organism for controlling Dipteran vectors and pests , 2015, Journal of enzyme inhibition and medicinal chemistry.

[19]  C. Supuran,et al.  6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells. , 2015, Journal of medicinal chemistry.

[20]  C. Supuran,et al.  Carbonic anhydrase and acetylcholinesterase inhibitory effects of carbamates and sulfamoylcarbamates , 2015, Journal of enzyme inhibition and medicinal chemistry.

[21]  C. Supuran,et al.  Synthesis and biological activity of novel thiourea derivatives as carbonic anhydrase inhibitors , 2015, Journal of enzyme inhibition and medicinal chemistry.

[22]  C. De Monte,et al.  Computational investigation of the selectivity of salen and tetrahydrosalen compounds towards the tumor-associated hCA XII isozyme , 2015, Journal of enzyme inhibition and medicinal chemistry.

[23]  C. Supuran,et al.  Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups. , 2014, Journal of medicinal chemistry.

[24]  C. Supuran,et al.  Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors , 2013, Expert opinion on drug discovery.

[25]  Chung Hyeok Kim,et al.  Biomedical Importance of Indoles , 2013, Molecules.

[26]  C. Supuran,et al.  Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? , 2012, Chemical reviews.

[27]  Parasa Hazarika,et al.  Efficient Synthesis of bis- and tris-Indolylalkanes Catalyzed by a Brønsted Acid–Surfactant Catalyst in Water , 2008 .

[28]  Claudiu T. Supuran,et al.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators , 2008, Nature Reviews Drug Discovery.

[29]  J. Wanders,et al.  A phase I and pharmacokinetic study of indisulam in combination with carboplatin , 2007, British Journal of Cancer.

[30]  C. Supuran,et al.  Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. , 2005, Journal of medicinal chemistry.

[31]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. , 2005, Bioorganic & medicinal chemistry letters.

[32]  Claudiu T Supuran,et al.  Indisulam: an anticancer sulfonamide in clinical development , 2003, Expert opinion on investigational drugs.

[33]  C. Supuran,et al.  Carbonic anhydrase activators. Part 14. Syntheses of mono and bis pyridinium salt derivatives of 2-amino-5-(2-aminoethyl)- and 2-amino-5-(3-aminopropyl)-1,3,4-thiadiazole and their interaction with isozyme II , 1996 .

[34]  C. Supuran,et al.  Carbonic anhydrase inhibitors. Part 35. Synthesis of Schiff bases derived from sulfanilamide and aromatic aldehydes: the first inhibitors with equally high affinity towards cytosolic and membrane-bound isozymes* , 1996 .

[35]  R. Khalifah,et al.  The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C. , 1971, The Journal of biological chemistry.